Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform

Martin C. Mahoney; Rebecca Ashare; Nicolas Schlienz; Ce Ce Duerr; Larry W. Hawk

doi:10.1016/j.jsat.2020.108100

Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform

Martin C. Mahoney
, Rebecca Ashare
, Nicolas Schlienz
, Ce Ce Duerr
, Larry W. Hawk

Psychology

University at Buffalo

Roswell Park Cancer Institute
SUNY Buffalo

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.

Original language	English
Article number	108100
Journal	Journal of Substance Abuse Treatment
Volume	117
DOIs	https://doi.org/10.1016/j.jsat.2020.108100
State	Published - Oct 2020

Access to Document

10.1016/j.jsat.2020.108100

Cite this

@article{cd5968c2faac40e7b5b3b626f3b4a758,

title = "Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform",

abstract = "Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.",

author = "Mahoney, \{Martin C.\} and Rebecca Ashare and Nicolas Schlienz and Duerr, \{Ce Ce\} and Hawk, \{Larry W.\}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = oct,

doi = "10.1016/j.jsat.2020.108100",

language = "English",

volume = "117",

journal = "Journal of Substance Abuse Treatment",

issn = "0740-5472",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Making lemonade from SARS coronavirus-2 lemons

T2 - Transitioning a smoking cessation trial to a virtual platform

AU - Mahoney, Martin C.

AU - Ashare, Rebecca

AU - Schlienz, Nicolas

AU - Duerr, Ce Ce

AU - Hawk, Larry W.

PY - 2020/10

Y1 - 2020/10

N2 - Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.

AB - Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.

UR - https://www.scopus.com/pages/publications/85089134465

U2 - 10.1016/j.jsat.2020.108100

DO - 10.1016/j.jsat.2020.108100

M3 - Article

C2 - 32811627

SN - 0740-5472

VL - 117

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

M1 - 108100

ER -

Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform

Abstract

Access to Document

Other files and links

Fingerprint

Cite this